Sarepta Therapeutics Inc (NASDAQ: SRPT) stock closed at $22.35 on 10/2/25 after a major increase of 15.7%. Moreover, above average trading volume at 146% of normal accompanied the advance. Relative to the market the stock has been extremely weak over the last nine months but has risen 22.4% during the last week.
Current PriceTarget Research Rating
Sarepta Therapeutics has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Sarepta Therapeutics has a very high Appreciation Score of 94 but a very low Power Rating of 3, and the Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment